Romiplostim for chemotherapy-induced thrombocytopenia (CIT) in colorectal, gastroesophageal, and pancreatic cancers: A global, phase 3, randomized, placebo-controlled trial (RCT).

Authors: Hanny Al-Samkari, Cesar Munoz, Caglayan Geredeli, Ippokratis Korantzis, Beatriz Gonzalez Astorga, Cagatay Arslan, Johnny Francisco Cordeiro Camargo, Florian Scotte, Giuliano Borges, Kejia Wang, Melissa Eisen, David Kuter, Gerald A. Soff

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.12007

Source: Full article

---

Abstract

12007